Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""British Journal of Haematology"" wg kryterium: JN

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 29
Tytuł:
Impact of polymorphisms in apoptosis-related genes on the outcome of childhood acute lymphoblastic leukaemia.
Autorzy:
Cabezas M; Unit of Biological Anthropology, Department of Animal Biology, Plant Biology and Ecology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Catalonia, Spain.
Camós M; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Catalonia, Spain.; Haematology Laboratory, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Catalonia, Spain.; National Biomedical Research Institute on Rare Diseases (CIBER ER), Instituto de Salud Carlos III, Madrid, Spain.
Rives S; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Catalonia, Spain.; National Biomedical Research Institute on Rare Diseases (CIBER ER), Instituto de Salud Carlos III, Madrid, Spain.; Paediatric Haematology and Oncology Department, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Catalonia, Spain.
Garcia-Orad A; Department of Genetics, Physic Anthropology and Animal Physiology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.; BioCruces Health Research Institute, Barakaldo, Bizkaia, Spain.
Lopez-Lopez E; Department of Genetics, Physic Anthropology and Animal Physiology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.
Dapena JL; Service of Paediatric Haematology and Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Caballín MR; Unit of Biological Anthropology, Department of Animal Biology, Plant Biology and Ecology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Catalonia, Spain.
Armengol G; Unit of Biological Anthropology, Department of Animal Biology, Plant Biology and Ecology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Catalonia, Spain.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 159-162. Date of Electronic Publication: 2018 May 29.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Apoptosis/*genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics
Child ; Dexamethasone/pharmacology ; Genes, p53 ; Genotype ; Glutathione Transferase/genetics ; Humans ; Jurkat Cells ; Kaplan-Meier Estimate ; Neoplasm Proteins/genetics ; Precision Medicine ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Survival Rate ; Treatment Outcome
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.
Autorzy:
Zhou J; Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL, USA.
Han J; Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL, USA.; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.; Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, Chicago, IL, USA.
Nutescu EA; Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL, USA.
Galanter WL; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.; Department of Medicine, Section of Academic Internal Medicine & Geriatrics, University of Illinois at Chicago, Chicago, IL, USA.
Walton SM; Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL, USA.
Gordeuk VR; Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, Chicago, IL, USA.
Saraf SL; Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, Chicago, IL, USA.
Calip GS; Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL, USA.; Division of Public Health Sciences, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 116-127. Date of Electronic Publication: 2019 Feb 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Black or African American*
Anemia, Sickle Cell/*complications
Anemia, Sickle Cell/*epidemiology
Diabetes Mellitus, Type 2/*complications
Diabetes Mellitus, Type 2/*epidemiology
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Cohort Studies ; Comorbidity ; Diabetes Mellitus, Type 2/diagnosis ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Population Surveillance ; Prevalence ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
Autorzy:
Böll B; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Plütschow A; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Bürkle C; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Atta J; Haematology Oncology, University Hospital Frankfurt, Frankfurt, Germany.
Pfreundschuh M; Haematology Oncology, University Hospital Saarland, Homburg, Germany.
Feuring-Buske M; Haematology Oncology, University Hospital Ulm, Ulm, Germany.
Vogelhuber M; Haematology Oncology, University Hospital Regensburg, Regensburg, Germany.
Sökler M; Haematology Oncology, University Hospital Tübingen, Tübingen, Germany.
Eichenauer DA; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Thielen I; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
von Tresckow B; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Fuchs M; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Engert A; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Borchmann P; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Pokaż więcej
Corporate Authors:
German Hodgkin Study Group (GHSG)
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 42-52. Date of Electronic Publication: 2018 Dec 28.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hodgkin Disease/*drug therapy
Age Factors ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dacarbazine/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Hodgkin Disease/diagnosis ; Hodgkin Disease/mortality ; Humans ; Lenalidomide/administration & dosage ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Treatment Outcome ; Vinblastine/administration & dosage
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma.
Autorzy:
Paczkowska J; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Soloch N; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Bodnar M; Department of Clinical Pathomorphology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.; Department of Otolaryngology and Laryngological Oncology, Poznan University of Medical Science, Poznan, Poland.
Kiwerska K; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.; Department of Tumour Pathology, Greater Poland Cancer Centre, Poznan, Poland.
Janiszewska J; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Vogt J; Institute of Human Genetics, Ulm University & Ulm University Medical Centre, Ulm, Germany.
Domanowska E; Department of Clinical Pathomorphology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
Martin-Subero JI; Insitut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Ammerpohl O; Institute of Human Genetics, Ulm University & Ulm University Medical Centre, Ulm, Germany.; Institute of Human Genetics, Christian-Albrechts-University Kiel, Kiel, Germany.
Klapper W; Department of Pathology, Hematopathology Section and Lymph Node Registry, Christian-Albrechts-University Kiel, Kiel, Germany.
Marszalek A; Department of Tumour Pathology and Prophylaxis, Poznan University of Medical Sciences & Greater Poland Cancer Centre, Poznan, Poland.
Siebert R; Institute of Human Genetics, Ulm University & Ulm University Medical Centre, Ulm, Germany.; Institute of Human Genetics, Christian-Albrechts-University Kiel, Kiel, Germany.
Giefing M; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.; Institute of Human Genetics, Christian-Albrechts-University Kiel, Kiel, Germany.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 79-88. Date of Electronic Publication: 2019 Jan 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
ETS Motif*/genetics
Gene Deletion*
Hodgkin Disease/*diagnosis
Hodgkin Disease/*genetics
Nuclear Proteins/*genetics
Transcription Factors/*genetics
B-Lymphocytes/metabolism ; B-Lymphocytes/pathology ; Biopsy ; Cell Line, Tumor ; DNA Methylation ; Heterozygote ; Hodgkin Disease/metabolism ; Humans ; Immunohistochemistry ; Mutation ; Nuclear Proteins/chemistry ; Nuclear Proteins/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Transcription Factors/chemistry ; Transcription Factors/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A significant proportion of children of African descent with HbSβ thalassaemia are inaccurately diagnosed based on phenotypic analyses alone.
Autorzy:
Day ME; Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
Rodeghier M; Rodeghier Consultants, Chicago, IL, USA.
Driggers J; Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Bean CJ; Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Volanakis EJ; Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
DeBaun MR; Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 153-156. Date of Electronic Publication: 2018 May 24.
Typ publikacji:
Letter
MeSH Terms:
Diagnostic Errors*
Anemia, Sickle Cell/*diagnosis
beta-Thalassemia/*diagnosis
Africa/ethnology ; Anemia, Sickle Cell/ethnology ; Anemia, Sickle Cell/genetics ; Child ; False Positive Reactions ; Heterozygote ; Humans ; Phenotype ; Sequence Deletion ; Sickle Cell Trait/diagnosis ; Sickle Cell Trait/ethnology ; Sickle Cell Trait/genetics ; alpha-Globins/genetics ; beta-Thalassemia/ethnology ; beta-Thalassemia/genetics
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?
Autorzy:
Nakasone H; Division of Haematology, Saitama Medical Centre, Jichi Medical University, Saitama, Japan.
Tabuchi K; Department of Paediatrics and Data Centre, Tokyo Metropolitan Cancer and Infectious Diseases Centre, Komagome Hospital, Tokyo, Japan.
Uchida N; Department of Haematology, Toranomon Hospital, Tokyo, Japan.
Ohno Y; Department of Internal Medicine, Kitakyushu Municipal Medical Centre, Kitakyushu, Japan.
Matsuhashi Y; Department of Haematology, Kawasaki Medical School Hospital, Kurashiki, Japan.
Takahashi S; Division of Molecular Therapy, The Advanced Clinical Research Centre, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Onishi Y; Department of Haematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
Onizuka M; Department of Haematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Kobayashi H; Department of Haematology, Nagano Red Cross Hospital, Nagano, Japan.
Fukuda T; Haematopoietic Stem Cell Transplantation Division, National Cancer Centre Hospital, Tokyo, Japan.
Ichinohe T; Department of Haematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Takanashi M; Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Kato K; Department of Haematology and Oncology, Children's Medical Centre, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Atsuta Y; Japanese Data Centre for Haematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yabe H; Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan.
Kanda Y; Division of Haematology, Saitama Medical Centre, Jichi Medical University, Saitama, Japan.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 166-169. Date of Electronic Publication: 2018 May 29.
Typ publikacji:
Comparative Study; Evaluation Study; Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Cord Blood Stem Cell Transplantation*/adverse effects
Antigens, CD34/*analysis
Cell Nucleus/*ultrastructure
Fetal Blood/*cytology
Child ; Graft Survival ; Graft vs Host Disease/epidemiology ; Graft vs Host Disease/etiology ; Humans ; Infant, Newborn ; Leukemia/therapy ; Lymphoma/therapy ; Middle Aged ; Neutrophils/cytology ; Retrospective Studies ; Risk
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bittersweet news for the adult sickle cell patient.
Autorzy:
Rund D; Department of Haematology, Hebrew University-Hadassah Medical Organization, Jerusalem, Israel.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 9-10. Date of Electronic Publication: 2019 Feb 03.
Typ publikacji:
Editorial; Letter
MeSH Terms:
Anemia, Sickle Cell/*epidemiology
Adult ; Age Factors ; Anemia, Sickle Cell/etiology ; Comorbidity ; Humans ; Population Surveillance
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study.
Autorzy:
Moreno C; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Delgado J; Hospital Clinic, Barcelona, Spain.
Byrd JC; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Zvagelsky WL; Johns Hopkins University, Baltimore, MD, USA.
Suzuki S; Pharmacyclics, LLC, an AbbVie Company, Sunnyvale, CA, USA.
Hsu E; Pharmacyclics, LLC, an AbbVie Company, Sunnyvale, CA, USA.
James DF; Pharmacyclics, LLC, an AbbVie Company, Sunnyvale, CA, USA.
Montserrat E; Hospital Clinic, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 148-150. Date of Electronic Publication: 2018 May 31.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Lymphocytic, Chronic, B-Cell/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Bone Marrow/pathology ; Chromosome Aberrations ; Clinical Trials, Phase III as Topic ; Humans ; Immunoglobulin Heavy Chains/genetics ; Kaplan-Meier Estimate ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Middle Aged ; Neoplasm Staging ; Patient Outcome Assessment ; Prognosis
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia.
Autorzy:
Belisário AR; Centro de Tecidos Biológicos de Minas Gerais, Fundação Hemominas, Lagoa Santa, MG, Brazil.; Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.; Faculdade de Medicina/Núcleo de Ações e Pesquisa em Apoio Diagnóstico (NUPAD), UFMG, Belo Horizonte, MG, Brazil.
Vieira ÉLM; Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
de Almeida JA; Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Mendes FG; Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Miranda AS; Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Rezende PV; Faculdade de Medicina/Núcleo de Ações e Pesquisa em Apoio Diagnóstico (NUPAD), UFMG, Belo Horizonte, MG, Brazil.
Viana MB; Faculdade de Medicina/Núcleo de Ações e Pesquisa em Apoio Diagnóstico (NUPAD), UFMG, Belo Horizonte, MG, Brazil.
Simões E Silva AC; Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 190-193. Date of Electronic Publication: 2018 Jul 05.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuminuria/*etiology
Albuminuria/*urine
Anemia, Sickle Cell/*complications
Peptidyl-Dipeptidase A/*urine
Age Factors ; Albuminuria/diagnosis ; Anemia, Sickle Cell/diagnosis ; Angiotensin-Converting Enzyme 2 ; Biomarkers ; Child ; Disease Susceptibility ; Humans ; Renin-Angiotensin System
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pleural effusion at diagnosis predicts extremely poor outcomes in patients with diffuse large B-cell lymphoma harbouring MYC rearrangement.
Autorzy:
Nitta H; Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan.
Gotoh A; Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan.
Tanaka M; Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan.
Sekiguchi Y; Department of Haematology, Juntendo University Urayasu Hospital, Urayasu, Japan.
Ota Y; Department of Pathology, Research Hospital, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Noguchi M; Department of Haematology, Juntendo University Urayasu Hospital, Urayasu, Japan.
Komatsu N; Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 183-187. Date of Electronic Publication: 2018 Jul 05.
Typ publikacji:
Letter
MeSH Terms:
Gene Rearrangement*
Genes, myc*
Lymphoma, Large B-Cell, Diffuse/*genetics
Lymphoma, Large B-Cell, Diffuse/*mortality
Pleural Effusion, Malignant/*pathology
Humans ; Lymphoma, Large B-Cell, Diffuse/diagnosis ; Lymphoma, Large B-Cell, Diffuse/therapy ; Prognosis ; Survival Analysis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intravenous iron treatment reduces coagulability in patients with iron deficiency anaemia: a longitudinal study.
Autorzy:
Nashashibi J; Internal Medicine D, Rambam Health Care Campus, Haifa, Israel.
Avraham GR; Internal Medicine C, Emek Medical Centre, Afula, Israel.
Schwartz N; Internal Medicine C, Emek Medical Centre, Afula, Israel.
Awni Y; Faculty of Medicine, Bar-Ilan University, Tzfat, Israel.
Elias M; Internal Medicine C, Emek Medical Centre, Afula, Israel.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 93-101. Date of Electronic Publication: 2019 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia, Iron-Deficiency/*blood
Anemia, Iron-Deficiency/*drug therapy
Blood Coagulation/*drug effects
Iron/*administration & dosage
Adult ; Anemia, Iron-Deficiency/diagnosis ; Anemia, Iron-Deficiency/etiology ; Blood Cell Count ; Female ; Humans ; Infusions, Intravenous ; Longitudinal Studies ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HAX-1 overexpression in multiple myeloma is associated with poor survival.
Autorzy:
Feng X; Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Kwiecinska A; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Rossmann E; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Bottai M; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Ishikawa T; Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Patarroyo M; Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Österborg A; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Porwit A; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Zheng C; Department of Haematology, Second Hospital, Shandong University, Jinan, China.; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
Fadeel B; Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 179-183. Date of Electronic Publication: 2018 Jun 19.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Gene Expression*
Adaptor Proteins, Signal Transducing/*genetics
Multiple Myeloma/*genetics
Multiple Myeloma/*mortality
Humans ; Kaplan-Meier Estimate ; Multiple Myeloma/diagnosis ; Prognosis
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
Autorzy:
Rosenbaum CA; Meyer Cancer Center, Weill Medical College of Cornell University and New York-Presbyterian Hospital, New York, NY, USA.
Jung SH; MD Anderson Cancer Center, Houston, TX, USA.
Pitcher B; MD Anderson Cancer Center, Houston, TX, USA.; Alliance Statistics and Data Center, Duke University, Durham, NC, USA.
Bartlett NL; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Smith SM; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
Hsi E; Cleveland Clinic, Cleveland, OH, USA.
Wagner-Johnston N; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Thomas SP; VA Central California Fresno Medical Center, Fresno, CA, USA.
Leonard JP; Meyer Cancer Center, Weill Medical College of Cornell University and New York-Presbyterian Hospital, New York, NY, USA.
Cheson BD; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, USA.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 53-64. Date of Electronic Publication: 2019 Feb 05.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
Lymphoma, Follicular/*drug therapy
Adult ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Biomarkers ; Female ; Humans ; Lymphoma, Follicular/diagnosis ; Lymphoma, Follicular/mortality ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Carcinocythaemia in an advanced stage of invasive ductal carcinoma of the breast.
Autorzy:
Oliver-Caldes A; Department of Haematology, Hospital Clinic de Barcelona, Barcelona, Spain.
Gonzalez-Farre B; Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain.
Merino A; Biomedical Diagnostic Centre, Hospital Clínic of Barcelona, Barcelona, Spain.
Rozman M; Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 8. Date of Electronic Publication: 2018 Nov 26.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Breast Neoplasms/*diagnosis
Carcinoma, Ductal, Breast/*diagnosis
Aged ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Biomarkers ; Biopsy ; Breast Neoplasms/therapy ; Carcinoma, Ductal, Breast/therapy ; Female ; Humans ; Immunohistochemistry ; Leukocyte Count ; Neoplasm Grading ; Neoplasm Staging ; Neoplastic Cells, Circulating/metabolism ; Neoplastic Cells, Circulating/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine-induced peripheral neuropathy in patients with lymphoma.
Autorzy:
Azoulay D; Haematology Unit and Laboratories, Galilee Medical Centre, Naharia& Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Nasser R; Department of Haematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
Sharon R; Haematology Unit and Laboratories, Galilee Medical Centre, Naharia& Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Simanovich L; Haematology Unit and Laboratories, Galilee Medical Centre, Naharia& Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Akria L; Haematology Unit and Laboratories, Galilee Medical Centre, Naharia& Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Shaoul E; Haematology Unit and Laboratories, Galilee Medical Centre, Naharia& Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Horowitz NA; Department of Haematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 175-177. Date of Electronic Publication: 2018 Jun 25.
Typ publikacji:
Letter
MeSH Terms:
Amino Acid Substitution*
Polymorphism, Single Nucleotide*
Brain-Derived Neurotrophic Factor/*blood
Brain-Derived Neurotrophic Factor/*genetics
Lymphoma/*complications
Lymphoma/*genetics
Peripheral Nervous System Diseases/*etiology
Vincristine/*adverse effects
Alleles ; Disease Susceptibility ; Female ; Genotype ; Humans ; Lymphoma/drug therapy ; Male ; Vincristine/therapeutic use
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Venous thromboembolic risk assessment in pregnancy: comparison of the All-Wales maternity risk assessment tool with guidance from the Royal College of Obstetrics and Gynaecology.
Autorzy:
Shacaluga A; Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK.
Rayment R; Department of Haematology, University Hospital of Wales, Cardiff, UK.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 162-165. Date of Electronic Publication: 2018 Aug 10.
Typ publikacji:
Letter
MeSH Terms:
Pregnancy Complications, Hematologic/*epidemiology
Pregnancy Complications, Hematologic/*etiology
Venous Thromboembolism/*epidemiology
Venous Thromboembolism/*etiology
Female ; Health Surveys ; Humans ; Practice Guidelines as Topic ; Pregnancy ; Risk Assessment ; Risk Factors ; United Kingdom/epidemiology
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia.
Autorzy:
Milani G; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Matthijssens F; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Van Loocke W; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Durinck K; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Roels J; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Peirs S; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Thénoz M; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Pieters T; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Laboratory, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium.; VIB Inflammation Research Centre, Ghent University, Ghent, Belgium.
Reunes L; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Lintermans B; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Vandamme N; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Laboratory, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium.; VIB Inflammation Research Centre, Ghent University, Ghent, Belgium.
Lammens T; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
Van Roy N; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Van Nieuwerburgh F; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
Deforce D; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
Schwab C; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Raimondi S; Department of Pathology and the Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
Dalla Pozza L; The Cancer Centre for Children, The Children's Hospital, Westmead, Australia.
Carroll AJ 3rd; University of Alabama at Birmingham, Birmingham, AL, USA.
De Moerloose B; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
Benoit Y; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
Goossens S; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Laboratory, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Berx G; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Laboratory, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Harrison CJ; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Basso G; Women and Child Health Department, Haematology-Oncology Laboratory Istituto di Ricerca Pediatrica (IRP), University of Padova, Padova, Italy.
Cavé H; Department of Genetics, University Hospital of Robert Debré and Paris-Diderot University, Paris, France.
Sutton R; Children's Cancer Institute, Lowy Cancer Research Centre UNSW, Sydney, New South Wales, Australia.
Asnafi V; Laboratory of Onco-Haematology, Institut Necker Enfants-Malades, INSERM U1151, Paris, France.
Meijerink J; The Máxima Centre for Paediatric Oncology/Haematology, Utrecht, the Netherlands.
Mullighan C; Department of Pathology and the Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
Loh M; Department of Pediatrics, UCSF Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Van Vlierberghe P; Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 169-174. Date of Electronic Publication: 2018 Jun 25.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Rearrangement*
Genes, myc*
Genetic Predisposition to Disease*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*genetics
Animals ; Biomarkers, Tumor ; DNA Copy Number Variations ; Disease Models, Animal ; Genetic Association Studies ; Humans ; Mice ; Molecular Targeted Therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Translocation, Genetic ; Xenograft Model Antitumor Assays
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival.
Autorzy:
Galleu A; King's College London, London, UK.; King's Health Partners Cancer Research UK Centre, London, UK.
Milojkovic D; Imperial College Healthcare NHS Trust, London, UK.
Deplano S; Imperial College Healthcare NHS Trust, London, UK.
Szydlo R; Imperial College London, London, UK.
Loaiza S; Imperial College Healthcare NHS Trust, London, UK.
Wynn R; Central Manchester University Hospital, Manchester, UK.
Marks DI; University Hospitals Bristol, Bristol, UK.
Richardson D; University Hospital Southampton, Southampton, UK.
Orchard K; University Hospital Southampton, Southampton, UK.
Kanfer E; Imperial College Healthcare NHS Trust, London, UK.
Tholouli E; Central Manchester University Hospital, Manchester, UK.
Saif M; Central Manchester University Hospital, Manchester, UK.
Sivaprakasam P; University Hospitals Bristol, Bristol, UK.
Lawson S; Birmingham Women's and Children's Hospitals, Birmingham, UK.
Bloor A; The Christie NHS Foundation Trust, Manchester, UK.
Pagliuca A; King's College Hospital NHS Trust, London, UK.
Potter V; King's College Hospital NHS Trust, London, UK.
Mehra V; King's College Hospital NHS Trust, London, UK.
Snowden JA; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Vora A; Sheffield Children's Hospital, Sheffield, UK.
Kishore B; Heart of England, NHS Foundation Trust, Birmingham, UK.
Hunter H; Plymouth Hospitals NHS Trust, Plymouth, UK.
Apperley JF; Imperial College Healthcare NHS Trust, London, UK.; Imperial College London, London, UK.
Dazzi F; King's College London, London, UK.; King's Health Partners Cancer Research UK Centre, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; Imperial College London, London, UK.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 89-92. Date of Electronic Publication: 2019 Jan 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Graft vs Host Disease/*therapy
Mesenchymal Stem Cells/*metabolism
Adult ; Aged ; Biomedical Research ; Female ; Graft vs Host Disease/etiology ; Graft vs Host Disease/mortality ; Humans ; Male ; Mesenchymal Stem Cells/cytology ; Middle Aged ; Prognosis ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms.
Autorzy:
Kucine N; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA.
Al-Kawaaz M; Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
Hajje D; Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
Bussel J; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA.
Orazi A; Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 136-139. Date of Electronic Publication: 2018 May 16.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural
MeSH Terms:
Janus Kinase 2/*genetics
Polycythemia Vera/*diagnosis
Thrombocythemia, Essential/*diagnosis
Adolescent ; Bone Marrow/pathology ; Child ; Child, Preschool ; Diagnosis, Differential ; Female ; Humans ; Male ; Mutation, Missense ; Point Mutation ; Polycythemia Vera/enzymology ; Polycythemia Vera/genetics ; Polycythemia Vera/pathology ; Thrombocythemia, Essential/enzymology ; Thrombocythemia, Essential/genetics ; Thrombocythemia, Essential/pathology
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 29

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies